{"id":"W2010456462","doi":"10.3747/co.v17i3.511","title":"Adjuvant Interferon Alfa for Melanoma","year":2010,"lang":"en","type":"letter","venue":"Current Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adjuvant; Melanoma; Interferon; Alpha interferon; Interferon alfa; Oncology; Cancer research; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001469787,0.0003971275,0.0008403191,0.0005145707,0.001186859,0.0007984495,0.0007992701,0.01218582,0.002229253],"category_scores_gemma":[0.007228109,0.0003279552,0.0009132009,0.0004262241,0.0007125469,0.001330373,0.000394733,0.0105254,0.002239099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002446087,"about_ca_system_score_gemma":0.002336663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003984788,"about_ca_topic_score_gemma":0.0124296,"domain_scores_codex":[0.9989188,0.0004558454,0.0001403123,0.00009340917,0.0002593591,0.0001323828],"domain_scores_gemma":[0.9977857,0.001325411,0.00017521,0.00006741857,0.0003238339,0.0003223248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000429666,0.0001227703,0.002510568,0.0001875499,0.00004213401,0.009109105,0.00007932734,0.0001870437,0.001137852,0.001742658,0.9363633,0.0480881],"study_design_scores_gemma":[0.001604622,0.001008446,0.01112272,0.00119298,0.0001859694,0.0374949,0.0003525203,0.003047469,0.001677859,0.01321321,0.929011,0.00008829087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.00443855,0.008133867,0.0001871741,0.9642098,0.01528281,0.00003471906,0.0001031894,0.00004723544,0.007562566],"genre_scores_gemma":[0.03256093,0.008162945,0.0005083203,0.8935669,0.05314062,0.00006670375,0.0001145524,0.00002446858,0.01185453],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01218582,"threshold_uncertainty_score":0.0177477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09176909717185865,"score_gpt":0.3830876328531744,"score_spread":0.2913185356813158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}